Connor, Clark & Lunn Investment Management (CC&L)
TBPH icon

Connor, Clark & Lunn Investment Management (CC&L)’s Theravance Biopharma TBPH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$624K Buy
2024
Q3 		– Sell
2024
Q2 		$136K Buy
2022
Q2 		– Sell
2022
Q1 		$387K Buy
2021
Q4 		$365K Sell
2021
Q3 		$327K Buy